logo
logo
Sign in

Pulmonary Function Testing Systems Market Revenue, Application Industry Demand Analysis Report 2019

avatar
Rohit Kamble
Pulmonary Function Testing Systems Market Revenue, Application Industry Demand Analysis Report 2019

Market Research Future (MRFR), the global market for pulmonary function testing (PFT) systems will exhibit a strong CAGR of 8.20% CAGR from 2018 to 2023.

Pulmonary Function Testing Systems Market Scenario:

PFT systems are used for measuring lung volume, capacity, the rate of flow and gas exchange. The information derived from the test are accurate and help in diagnosing certain lung disorders as well as determining treatment or therapeutics for them.

Tests involved in assessing pulmonary function are non-invasive and mainly performed to identify respiratory issues. In recent years, issues related to respiration has increased to a substantial level partly due to factors such as climate change, rising air pollution and increased consumption of cigarette.

Get Free Sample at https://www.marketresearchfuture.com/sample_request/6603

Pulmonary Function Testing Systems Market Companies Covered:

  • Vyaire Medical
  • Inc, COSMED srl
  • Medical Equipment Europe GmbH
  • Schiller
  • Medical Electronic Construction
  • CHEST M.I. Inc
  • ECO MEDICS AG
  • MGC
  • Diagnostic Corporation
  • and ndd Medical Technologies.

Segmental Analysis:

MRFR’s report include an in-depth segmental analysis of the market based on type, test type, component, application, end-user, and region.

On the basis of type, the Pulmonary Function Testing Systems Market is segmented into complete PFT systems and portable PFT systems. The former will continue to outperform the later throughout the assessment period. In 2017, the complete PFT system accounted for more than 53% share of the market. The segment is projected to surge at 9.05% CAGR till 2023.

On the basis of test type, the Pulmonary Function Testing Systems Market is segmented into spirometry, gas exchange testing, lung volume, oxygen titration test, maximal voluntary ventilation, and high-altitude simulation testing.  Among these, the spirometry segment is expected to remain highly lucrative over the next couple of years. The stood at a market valuation of USD 649.6 million 2017 and is expected witness a double-digit CAGR during the assessment period.

Based on component, the Pulmonary Function Testing Systems Market has been segmented into software, hardware and service. The software segment in expected to remain highly attractive over 2023. In 2017, the segment accounted for over one-third share of the market.  

Based on application, the Pulmonary Function Testing Systems Market has been segmented into chronic shortness of breath, chronic obstructive pulmonary disease, restrictive lung disease, asthma. The chronic obstructive pulmonary disease segment currently holds the top position and the trend is likely to continue beyond 2018.

Based on end-user, the Pulmonary Function Testing Systems Market is segmented into diagnostics laboratories and hospital/clinical laboratories. The hospital/clinical laboratories segment accounted for 42.3% share of the market in 2017.

Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/pulmonary-function-testing-systems-market-6603

Pulmonary Function Testing Systems Market Regional Analysis:

The pulmonary function testing systems market has been covered across regions such as North America, the Middle East & Africa (MEA), South America, Europe and Asia Pacific (Asia Pacific).

The Americas market for pulmonary function testing systems is divided into North and South America with the North American market having a high concentration of developed economies. The Americas market leads the global market in terms of market size due to the ongoing innovation in diagnostics combined with the high prevalence of pulmonary diseases. The U.S accounts for the most important country-level market in the region. Europe has the second most significant market. Increasing initiatives to support the growth of PFT systems and devices due to increasing prices of the same have greatly impacted the market positively. However, reimbursement restrictions in the region with regards to medication will likely limit the development of the market over the assessment period.

The Asia Pacific is primarily led by country level markets such as Japan, China, India, and Korea. The region has been recognized for its potential for growth and the opportunities it represents. The presence of a massive patient population is expected to lead to rapid growth for the global pulmonary function testing systems market. High focus on the development of healthcare and the demand for pulmonary devices are expected to result in growth.

Inquire for Discounts at https://www.marketresearchfuture.com/check-discount/6603

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

+1 646 845 9312

Email: [email protected]

collect
0
avatar
Rohit Kamble
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more